1.325
price down icon5.04%   -0.065
 
loading
Precedente Chiudi:
$1.39
Aprire:
$1.39
Volume 24 ore:
796.40K
Relative Volume:
0.51
Capitalizzazione di mercato:
$351.25M
Reddito:
-
Utile/perdita netta:
$-125.04M
Rapporto P/E:
-1.6159
EPS:
-0.82
Flusso di cassa netto:
$-122.99M
1 W Prestazione:
+6.45%
1M Prestazione:
-13.16%
6M Prestazione:
-50.00%
1 anno Prestazione:
-30.16%
Intervallo 1D:
Value
$1.275
$1.405
Intervallo di 1 settimana:
Value
$1.23
$1.55
Portata 52W:
Value
$1.01
$3.45

Erasca Inc Stock (ERAS) Company Profile

Name
Nome
Erasca Inc
Name
Telefono
(858) 465-6511
Name
Indirizzo
10835 ROAD TO THE CURE, SUITE 140, SAN DIEGO
Name
Dipendente
129
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
ERAS's Discussions on Twitter

Confronta ERAS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ERAS
Erasca Inc
1.32 351.25M 0 -125.04M -122.99M -0.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.12 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
603.52 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
613.96 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
253.34 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.76 24.70B 3.81B -644.79M -669.77M -6.24

Erasca Inc Stock (ERAS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-26 Iniziato Raymond James Outperform
2024-11-18 Iniziato Jefferies Buy
2024-03-11 Iniziato CapitalOne Overweight
2024-01-05 Downgrade BofA Securities Buy → Neutral
2023-10-11 Iniziato H.C. Wainwright Buy
2023-03-30 Iniziato Mizuho Buy
2023-02-24 Iniziato Goldman Buy
2023-02-03 Aggiornamento Morgan Stanley Equal-Weight → Overweight
Mostra tutto

Erasca Inc Borsa (ERAS) Ultime notizie

pulisher
Apr 25, 2025

Erasca, Inc: Carving A Different Niche In RAS Signaling (NASDAQ:ERAS) - Seeking Alpha

Apr 25, 2025
pulisher
Apr 24, 2025

Check out these key findings about Erasca Inc (ERAS) - Sete News

Apr 24, 2025
pulisher
Apr 24, 2025

Analytical Overview: Erasca Inc (ERAS)’s Ratios Tell a Financial Story - DWinneX

Apr 24, 2025
pulisher
Apr 23, 2025

Erasca Inc (ERAS) may enjoy gains as insiders got busy in the recent days - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

ERAS’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

Apr 23, 2025
pulisher
Apr 23, 2025

Geode Capital Management LLC Grows Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 23, 2025
pulisher
Apr 21, 2025

JPMorgan Chase & Co. Lowers Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 21, 2025
pulisher
Apr 21, 2025

JPMorgan Chase & Co. Reduces Holdings in Erasca, Inc. (NASDAQ:ERAS) - American Banking and Market News

Apr 21, 2025
pulisher
Apr 16, 2025

Is Erasca Inc. (NASDAQ:ERAS) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Yahoo Finance

Apr 16, 2025
pulisher
Apr 14, 2025

Wellington Management Group LLP Acquires New Stake in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 14, 2025
pulisher
Apr 14, 2025

Vanguard Group Inc. Sells 614,840 Shares of Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 14, 2025
pulisher
Apr 12, 2025

KLP Kapitalforvaltning AS Makes New $69,000 Investment in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

Erasca, Inc. (NASDAQ:ERAS) Shares Acquired by American Century Companies Inc. - Defense World

Apr 11, 2025
pulisher
Apr 08, 2025

Erasca stock hits 52-week low at $1.02 amid market challenges By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 08, 2025

Erasca stock hits 52-week low at $1.02 amid market challenges - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Erasca Slides As Insider Purchases Lose Another US$84k - Yahoo Finance

Apr 08, 2025
pulisher
Apr 08, 2025

Erasca (NASDAQ:ERAS) vs. Merck KGaA (OTCMKTS:MKGAF) Head-To-Head Contrast - Defense World

Apr 08, 2025
pulisher
Apr 07, 2025

Erasca Inc (NASDAQ: ERAS) Stock Sentiment: What’s Wall Street Saying? - stocksregister.com

Apr 07, 2025
pulisher
Apr 05, 2025

Thrivent Financial for Lutherans Sells 29,263 Shares of Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 05, 2025
pulisher
Apr 04, 2025

Erasca, Inc. (NASDAQ:ERAS) Receives $4.83 Consensus Price Target from Brokerages - Defense World

Apr 04, 2025
pulisher
Apr 03, 2025

Teacher Retirement System of Texas Buys 12,345 Shares of Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

Erasca Insiders Lose Out As Stock Sinks To US$1.21 - simplywall.st

Apr 02, 2025
pulisher
Apr 01, 2025

Erasca stock hits 52-week low at $1.23 amid market challenges - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

Erasca stock hits 52-week low at $1.23 amid market challenges By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Mar 30, 2025

Erasca (NASDAQ:ERAS) Coverage Initiated by Analysts at Raymond James - MarketBeat

Mar 30, 2025
pulisher
Mar 30, 2025

Erasca, Inc. (NASDAQ:ERAS) Shares Bought by Swiss National Bank - Defense World

Mar 30, 2025
pulisher
Mar 27, 2025

Erasca (NASDAQ:ERAS) Now Covered by Analysts at Raymond James - Defense World

Mar 27, 2025
pulisher
Mar 26, 2025

Raymond James sets $5 target for Erasca stock, cites valuation gap By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Raymond James Initiates Coverage of Erasca (ERAS) with Outperform Recommendation - Nasdaq

Mar 26, 2025
pulisher
Mar 26, 2025

This Spotify Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

Raymond James sets $5 target for Erasca stock, cites valuation gap - Investing.com India

Mar 26, 2025
pulisher
Mar 26, 2025

Raymond James Initiates Erasca at Outperform With $5 Price Target - MarketScreener

Mar 26, 2025
pulisher
Mar 26, 2025

Erasca initiated with an Outperform at Raymond James - TipRanks

Mar 26, 2025
pulisher
Mar 26, 2025

Charles Schwab Investment Management Inc. Buys 39,066 Shares of Erasca, Inc. (NASDAQ:ERAS) - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Erasca Announces Three Poster Presentations at the 2025 AACR Annual Meeting - The Manila Times

Mar 25, 2025
pulisher
Mar 25, 2025

Game-Changing Cancer Treatments: Erasca Reveals 3 Novel Drug Breakthroughs at AACR 2025 - Stock Titan

Mar 25, 2025
pulisher
Mar 24, 2025

Bank of New York Mellon Corp Grows Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Mar 24, 2025
pulisher
Mar 24, 2025

What is HC Wainwright’s Estimate for Erasca FY2029 Earnings? - Defense World

Mar 24, 2025
pulisher
Mar 23, 2025

The Goldman Sachs Group Has Lowered Expectations for Erasca (NASDAQ:ERAS) Stock Price - Defense World

Mar 23, 2025
pulisher
Mar 23, 2025

Erasca (NASDAQ:ERAS) Earns “Buy” Rating from HC Wainwright - Defense World

Mar 23, 2025
pulisher
Mar 21, 2025

Erasca Reports Fourth Quarter and Full Year 2024 Business Updates and Financial Results - The Manila Times

Mar 21, 2025
pulisher
Mar 21, 2025

Erasca, Inc. Reports 2024 Financial and Strategic Progress - TipRanks

Mar 21, 2025
pulisher
Mar 20, 2025

Erasca Inc. (ERAS) reports earnings - Quartz

Mar 20, 2025
pulisher
Mar 20, 2025

ERASCA Earnings Results: $ERAS Reports Quarterly Earnings - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

Erasca, Inc. SEC 10-K Report - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Erasca's $440M War Chest Powers Two Groundbreaking Cancer Drugs Into 2025 Trials - StockTitan

Mar 20, 2025
pulisher
Mar 19, 2025

Erasca (ERAS) Expected to Announce Earnings on Wednesday - Defense World

Mar 19, 2025
pulisher
Mar 10, 2025

Brokerages Set Erasca, Inc. (NASDAQ:ERAS) Price Target at $5.70 - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Morgan Stanley Reaffirms Overweight Rating for Erasca (NASDAQ:ERAS) - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Rhumbline Advisers Boosts Stock Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Mar 08, 2025

Erasca Inc Azioni (ERAS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.65
price up icon 0.63%
$70.47
price up icon 1.28%
$32.49
price up icon 0.64%
$23.90
price up icon 1.85%
$108.35
price up icon 3.89%
biotechnology ONC
$247.87
price up icon 1.21%
Capitalizzazione:     |  Volume (24 ore):